US · Healthcare

Fulcrum Therapeutics Inc (FULC)

Biotechnology

Fulcrum Therapeutics Inc (FULC) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for FULC

P/E ratio

18.00

Fulcrum Therapeutics Inc (FULC) — FAQ

What is FULC's P/E ratio?

The price-to-earnings (P/E) ratio for Fulcrum Therapeutics Inc (FULC) is 18.00 (data as of 2026-03-24).

Does Fulcrum Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Fulcrum Therapeutics Inc (FULC). Check the MyAverix Finance app for the latest dividend data.

What sector is Fulcrum Therapeutics Inc in?

Fulcrum Therapeutics Inc (FULC) is classified in the Healthcare sector (Biotechnology industry).

What exchange is FULC listed on?

FULC is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)